Pure Health Holding PJSC

PUREHEALTHStocksAbu Dhabi Securities ExchangeHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	25.00B	23.00B	28.33B	31.67B	29.89B
Market Cap Growth	-14.4%	-29.4%	-23.4%	-20.8%	-36.4%
Enterprise Value	38.42B	33.54B	33.31B	37.10B	35.22B
Last Close Price	2.25	2.02	2.49	2.78	2.62
Valuation Multiples
Forward PE (Next 12M Est.)	15.54	10.03	14.57	15.23	12.95
PE Ratio	13.26	12.20	14.15	17.35	17.23
PS Ratio	0.89	0.82	1.04	1.17	1.11
PB Ratio	1.35	1.24	1.55	1.52	1.46
P/TBV Ratio	4.09	3.77	4.94	2.64	2.60
P/FCF Ratio	6.91	—	7.13	8.25	6.32
P/OCF Ratio	5.41	—	5.77	7.10	5.66
EV/Sales Ratio	1.37	1.20	1.22	1.37	1.31
EV/EBITDA Ratio	8.76	9.59	9.44	10.75	10.57
EV/EBIT Ratio	14.87	12.98	12.49	14.95	14.56
EV/FCF Ratio	10.62	—	8.38	9.66	7.44
Leverage & Capital
Debt / Equity Ratio	0.98	0.98	1.00	0.63	0.66
Debt / EBITDA Ratio	4.14	3.81	5.59	2.82	2.78
Debt / FCF Ratio	5.02	—	4.59	3.45	2.84
Net Debt / Equity Ratio	0.72	0.72	0.57	0.24	0.26
Net Debt / EBITDA Ratio	3.83	3.83	2.98	1.44	1.62
Net Debt / FCF Ratio	3.70	3.72	2.65	1.29	1.14
Efficiency & Liquidity
Asset Turnover	0.51	0.54	0.53	0.57	0.55
Inventory Turnover	14.53	15.23	16.31	15.18	16.89
Quick Ratio	1.08	1.08	1.15	1.44	1.40
Current Ratio	1.27	1.27	1.35	1.66	1.61
Returns & Yields
Return on Equity (ROE)	+9.0%	+9.6%	+10.1%	+10.3%	+10.2%
Return on Assets (ROA)	+3.0%	+1.6%	+3.8%	+4.0%	+4.0%
Return on Invested Capital (ROIC)	+2.1%	+1.2%	+2.7%	+2.6%	+3.0%
Return on Capital Employed (ROCE)	+6.3%	+6.3%	+6.3%	+6.8%	+6.7%
Earnings Yield	+7.5%	+8.2%	+7.1%	+5.8%	+5.8%
FCF Yield	+14.5%	+15.7%	+14.0%	+12.1%	+15.8%
Dividend Yield	+2.4%	—	+2.2%	—	—
Payout Ratio	+18.6%	—	+1.6%	—	+65.7%
Buyback Yield / Dilution	0.0%	0.0%	0.0%	—	—
Total Shareholder Return	+2.4%	0.0%	+2.2%	—	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	25.00B	23.00B	28.33B	31.67B	29.89B
Market Cap Growth	-14.4%	-29.4%	-23.4%	-20.8%	-36.4%
Enterprise Value	38.42B	33.54B	33.31B	37.10B	35.22B
Last Close Price	2.25	2.02	2.49	2.78	2.62
Valuation Multiples
Forward PE (Next 12M Est.)	15.54	10.03	14.57	15.23	12.95
PE Ratio	13.26	12.20	14.15	17.35	17.23
PS Ratio	0.89	0.82	1.04	1.17	1.11
PB Ratio	1.35	1.24	1.55	1.52	1.46
P/TBV Ratio	4.09	3.77	4.94	2.64	2.60
P/FCF Ratio	6.91	—	7.13	8.25	6.32
P/OCF Ratio	5.41	—	5.77	7.10	5.66
EV/Sales Ratio	1.37	1.20	1.22	1.37	1.31
EV/EBITDA Ratio	8.76	9.59	9.44	10.75	10.57
EV/EBIT Ratio	14.87	12.98	12.49	14.95	14.56
EV/FCF Ratio	10.62	—	8.38	9.66	7.44
Leverage & Capital
Debt / Equity Ratio	0.98	0.98	1.00	0.63	0.66
Debt / EBITDA Ratio	4.14	3.81	5.59	2.82	2.78
Debt / FCF Ratio	5.02	—	4.59	3.45	2.84
Net Debt / Equity Ratio	0.72	0.72	0.57	0.24	0.26
Net Debt / EBITDA Ratio	3.83	3.83	2.98	1.44	1.62
Net Debt / FCF Ratio	3.70	3.72	2.65	1.29	1.14
Efficiency & Liquidity
Asset Turnover	0.51	0.54	0.53	0.57	0.55
Inventory Turnover	14.53	15.23	16.31	15.18	16.89
Quick Ratio	1.08	1.08	1.15	1.44	1.40
Current Ratio	1.27	1.27	1.35	1.66	1.61
Returns & Yields
Return on Equity (ROE)	+9.0%	+9.6%	+10.1%	+10.3%	+10.2%
Return on Assets (ROA)	+3.0%	+1.6%	+3.8%	+4.0%	+4.0%
Return on Invested Capital (ROIC)	+2.1%	+1.2%	+2.7%	+2.6%	+3.0%
Return on Capital Employed (ROCE)	+6.3%	+6.3%	+6.3%	+6.8%	+6.7%
Earnings Yield	+7.5%	+8.2%	+7.1%	+5.8%	+5.8%
FCF Yield	+14.5%	+15.7%	+14.0%	+12.1%	+15.8%
Dividend Yield	+2.4%	—	+2.2%	—	—
Payout Ratio	+18.6%	—	+1.6%	—	+65.7%
Buyback Yield / Dilution	0.0%	0.0%	0.0%	—	—
Total Shareholder Return	+2.4%	0.0%	+2.2%	—	—